The endocannabinoid anandamide (AEA) is released by macrophages and microglia on pathological neuroinflammatory conditions such as multiple sclerosis (MS). CD200 is a membrane glycoprotein expressed in neurons that suppresses immune activity via its receptor (CD200R) mainly located in macrophages/microglia. CD200-CD200R interactions contribute to the brain immune privileged status. In this study, we show that AEA protects neurons from microglia-induced neurotoxicity via CD200-CD200R interacti...Expand abstract
- Publisher copy:
- Copyright date:
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
If you are the owner of this record, you can report an update to it here: Report update to this record